Introduction
============

Despite modern guidelines, ruling out or diagnosing pulmonary embolism (PE) represents one of the main medical problem in clinical geriatric practice (Rogers 2007). PE remains in fact an under-diagnosed disease in old people, even though its incidence, prevalence, morbidity, and mortality increase steadily with age ([@b24]; [@b18]; [@b46]; [@b16]; Heit et al 1999; [@b59]; [@b52]). It has been reported that PE represented the main cause of death that is less suspected by physicians in the elderly ([@b29]). About 40% of PE found at necropsy in older persons were not suspected ante mortem ([@b29]).

The diagnostic process of PE starts from clinical suspicion both in young adults and in elderly patients ([@b54]; [@b12]; [@b1]; [@b6]; [@b15]; [@b53]). Assessment of clinical probability represents the first step to reach a prompt diagnosis of PE and to prevent delays in the diagnostic work-up and initiation of appropriate treatment. Assessment of clinical probability derives from an integration of history, analysis of risk factors for venous thromboembolism (VTE), symptoms and signs with first level investigations such as systolic blood pressure, 12-leads electrocardiography (ECG), chest X-ray, and arterial blood gas analysis (ABG). Clinical pre-test probability (PTP) should be evaluated by using one of the available and validated score, such as the Wells' score or the Geneva score ([@b58]; [@b54]; [@b12]; [@b1]; [@b6]; [@b15]; [@b28]; [@b53]). After assessment of clinical probability, D-Dimer measurement is often the next proposed step in diagnostic strategies for suspected PE ([@b52]). However, D-Dimer assay should be performed only in nonhigh PTP (low or moderate PTP) ([@b6]). PE may be ruled out when nonhigh PTP is associated to negative D-Dimer (\<500 μg/L) ([@b54]; [@b12]; [@b1]; [@b6]; [@b15]; [@b33]; [@b60]; [@b53]). In the other cases, PE should be confirmed with helical pulmonary angio-computer tomography (angio-CT), preferably multidetector type, lung scan or pulmonary angiography ([@b54]; [@b12]; [@b1]; [@b6]; [@b15]; [@b53]). The use of lung scan for confirming PE has been reduced because of the major availability of helical angio-CT, and in reason of the important proportion of inconclusive lung scan, in particular in elderly patients. Legs ultrasonography is noninvasive, and is able to detect deep vein thrombosis (DVT). The presence of a recent DVT is enough to rule in the diagnosis of PE and DVT and start anticoagulation ([@b28]). Combination of PTP with different levels of D-Dimer could reduce the number of unnecessary legs ultrasonography for ruling out DVT in patients with symptomatic PE ([@b61]). Trans thoracic echocardiogram (TTE), is particularly useful in suspected massive PE, when unstability of patient precludes complicated diagnostic algorithms. Moreover it could offer information for prognosis stratification and aid the choice of treatment, as biomarkers (B natriuretic peptides and cardiac troponins) ([@b54]; [@b12]; [@b17]; [@b1]; [@b6]; [@b15]; [@b26]; [@b34]; [@b53]; [@b5]).

Since the evidence showed difficulties in diagnosing of PE in the elderly, the clinical, instrumental and laboratory presentation of PE in elderly patients are reviewed in the present article.

Sources were obtained from articles indexed in MEDLINE database from January 1987 to August 2007 searching terms "pulmonary embolism", "elderly", "old", "venous thromboembolism" in the title, abstract and/or text. Additional references were identified by reviewing the bibliographies of retrieved articles. Only prospective and retrospective English language studies dealing with the clinical, instrumental and/or laboratory presentation of PE patients aged more than 65 years were considered for the review. Studies were included if they reported patients with confirmed PE. We did not perform a systematic review, but we reported data of more relevant articles.

Results
=======

Symptoms, risk factors of VTE, first line instrumental examinations, and arterial blood gas analysis (ABG)
----------------------------------------------------------------------------------------------------------

These data derived from twelve selected articles ([@b7]; [@b49]; [@b22]; [@b14]; [@b31]; [@b36]; [@b9]; [@b57]; [@b25]; [@b27]; [@b35]; [@b10]). From ten of them, we derived data for acute mortality, symptoms, signs and risk factors for VTE ([@b7]; [@b49]; [@b14]; [@b31]; [@b36]; [@b9]; [@b57]; [@b25]; [@b27]; [@b35]); from seven articles we derived data for 12-leads ECG ([@b49]; [@b31]; [@b36]; [@b9]; [@b57]; [@b25]), from six data for chest X-ray ([@b7]; [@b49]; [@b31]; [@b36]; [@b9]; [@b27]), from four data for TTE and from seven data for ABG ([@b49]; [@b22]; [@b14]; [@b31]; [@b36]; [@b9]; [@b25]).

Dyspnea (range 59%--91.5%), tachypnea (46%--74%), tachycardia (29%--76%), and chest pain (range 26%--59%) represented the main symptoms reported in clinical studies about PE in the elderly. Bed rest (range 15%--67%) and DVT (range 15%--50%) were the main risk factors for VTE ([Table 1](#tbl1){ref-type="table"}).

###### 

Main clinical aspects of elderly patients with PE

  Reference Year           [@b7]      [@b49]                  Gisselbrecht 1996                    [@b36]                                Masotti 2003   [@b9]        [@b57]    Punukollu 2005   Koktur 2005   [@b27]      Tot./Range (1988--2005)
  ------------------------ ---------- ----------------------- ------------------------------------ ------------------------------------- -------------- ------------ --------- ---------------- ------------- ----------- -------------------------
  Type of study            R          P                       P                                    R                                     R              R            R         P                R             P           
  Diagnostic               V/Q scan                           V/Q scan/                            Q scan/                               V/Q scan/      Q scan       Q scan    hCT              V/Q scan/     V/Q scan    hCT
  Method                              pulmonary angiography   pulmonary angiography                pulmonary angiography                                                       hCT                                        
  Patient Number           37         72                      26                                   64                                    68             59           29        70               58            167         650
  Male/female              17/20      32/40                   10/16                                24/40                                 22/46          18/41        12/17     29/41            21/37         61/106      246/404
  Mean Age(years ± SD)     76         ≥70                     80 ± 3                               69 ± 17                               78.6 ± 7.7     81.9 ± 5.2   74.7      76.4 ± 8.37      72.7 ± 6.1    ≥75         (65--99)
  Mortality                21.6%      nr                      11.5%                                8%                                    29.5%          32%          nr        17%              nr            nr          (8%--32%)
  **Symptoms and signs**                                                                                                                                                                                                  
  **Dyspnea**              **65%**    **78%**                 **85%**                              **66%**                               **88%**        **91.5%**    **59%**   **74%**          **84.5%**     **81.9%**   **(59--91.5%)**
  Tachycardia              nr         29%                     nr[§](#tf1-3){ref-type="table-fn"}   nr[\*](#tf1-2){ref-type="table-fn"}   74%            67%          31%       44%              nr            32.9%       (29--76%)
  Chest pain               57%        51%                     35%                                  27%                                   40%            39%          59%       26%              48.3%         46.1%       (26--57%)
  Tachypnea                46%        74%                     nr                                   nr                                    50%            47%          nr        nr               nr            73.1%       (46--74%)
  Syncope                  8%         nr                      62%                                  11%                                   13.5%          20%          nr        19%              27.6%         18.6%       (8--62%)
  Shock                    5%         10%                     31%                                  nr                                    13.5%          18%          24%       nr               nr            nr          (5--31%)
  Cough                    43%        35%                     nr                                   12%                                   22%            20%          24%       nr               16%           nr          (12--43%)
  Hemoptysis               11%        8%                      0%                                   3%                                    nr             nr           14%       nr               6.9%          4.8%        (3--14%)
  **Risk factors**                                                                                                                                                                                                        
  **Bed rest**             **25%**    **67%**                 **15%**                              **45%**                               **65%**        **54%**      **nr**    **21%**          **40%**       **nr**      **(15%--67%)**
  **DVT**                  **16%**    **15%**                 **50%**                              **47%**                               **35%**        **34%**      **16%**   **19%**          **44.8%**     **nr**      **(15%--50%)**
  **Cancer**               **32%**    **26%**                 **4%**                               **20%**                               **16.5%**      **18.5%**    **nr**    **30%**          **13.8%**     **9.0%**    **(4%--32%)**
  **Surgery**              **22%**    **44%**                 **19%**                              **14%**                               **7%**         **5%**       **nr**    **9%**           **26%**       **6.6%**    **(5%--44%)**
  Heart failure            30%        nr                      nr                                   33%                                   25%            32%          nr        nr               5%            15%         (5%--33%)
  Previous DVT/PE          27%        nr                      19%                                  18%                                   24%            23.5%        nr        19%              35%           41%         (18%--41%)
  Stroke                   11%        nr                      nr                                   nr                                    13.5%          12%          nr        nr               nr            3%          (3%--13.5%)
  AMI                      11%        nr                      nr                                   nr                                    nr             3%           nr        nr               nr            nr          (3%--11%)
  COPD                     nr         nr                      nr                                   nr                                    13.5%          27%          nr        nr               2%            8.4%        (2%--27%)

**Abbreviations:**DVT, deep vein thrombosis; AMI, Acute myocardial infarction; COPD, chronic obstructive pulmonary disease; nr, not reported;

Mean heart rate 95 ± 17 beats for minute;

mean heart rate 100 ± 16 beats for minute;

°Right ventricular failure 46%; the study of Gisselbrecht^15^ was referred to massive pulmonary embolism. V, ventilation; Q, perfusion; hCT, helical computer tomography. R, retrospective; P, prospective.

Sinus tachycardia (range 18%--62.5%), right bundle branch block (4.5%--40.5%) and ST-T abnormalities (9%--37%) were the most represented 12-leads-ECG findings; the typical S1Q3/S1Q3T3 ECG pattern was found in 4.5%--14% of patients.

Three studies reported abnormalities in less of one half of patients at chest X-ray ([@b7]; [@b36]; [@b27]) while in other three studies more than 70% of patients had abnormalities ([@b49]; [@b31]; [@b9]). Cardiomegaly (range 22%--64%), pleural effusion (15.8%--57%), and (8.5%--71%) were the most frequent reported aspects. More than 50% of patients had features of right heart overload at TTE ([@b31]; [@b9]; [@b25]; [@b10]).

A severe hypoxemic respiratory failure was found as main ABG pattern. In five studies, this pattern was associated to low arterial carbon dioxide partial pressure (PaCO~2~). In three studies the alveolar-arterial oxygen gradient, D(A-a)O~2~, was analyzed ([@b22]; [@b31]; [@b9]), and was found to be elevated (range 44.8--46.6 mmHg).

[Table 2](#tbl2){ref-type="table"} summarizes the first line instrumental findings.

###### 

12-leads electrocardiography, chest X-ray, arterial blood gas analysis findings **12-leads ECG**

  Reference Year               [@b49]    [@b36]   **Masotti 2003**        [@b9]              [@b57]             [@b25]        **Tot./Range (1988--2005)**   
  ---------------------------- --------- -------- ----------------------- ------------------ ------------------ ------------- ----------------------------- -----------------------------
  Normal                       21%       nr       nr                      nr                 nr                 50%           (21%--50%)                    
  Sinus tachycardia            nr        nr       60%                     62.5%              18%                nr            (18%--62.5%)                  
  Atrial fibrillation          nr        20%      20%                     20.5%              7%                 13.6%         (7%--20.5%)                   
  RBBB                         9%        9%       27%                     40.5%              18%                4.5%          (4.5%--40.5%)                 
  S1Q3/S1Q3T3T3                nr        8%       12%                     8.5%               14%                4.5%          (4.5%--14%)                   
  ST-T abnormalities           56%       22%      34%                     51%                4%                 13.6%         (4%--56%)                     
  **Chest X-ray**                                                                                                                                           
                                                                                                                                                            
  Reference Year               [@b7]     [@b49]   [@b36]                  **Masotti 2003**   [@b9]              [@b27]        **Tot./Range (1988--2005)**   
                                                                                                                                                            
  Abnormal                     38%       96%      43%                     80.5%              86.5%              nr            (38%--96%)                    
  Cardiomegaly                 nr        22%      20%                     58%                64%                nr            (22%--64%)                    
  Pulmonary edema              nr        13%      nr                      13.5%              30.5%              nr            (13%--30.5%)                  
  Pleural effusion             16%       57%      nr                      18%                17%                15.8%         (15.8%--57%)                  
  Atelectasis                  22%       71%      14%                     15%                8.5%               14%           (8.5%--71%)                   
  Hemidiaphragm elevation      nr        28%      nr                      nr                 8.5%               18.2%         (8.5%--28%)                   
  **ABG**                                                                                                                                                   
                                                                                                                                                            
  **Reference Year**           [@b49]    [@b22]   **Gisselbrecht 1996**   [@b36]             **Masotti 2003**   [@b9]         [@b25]                        **Tot./Range (1988--2005)**
                                                                                                                                                            
  Mean paO~2~(mmHg)            61 ± 12   61.4     55 ± 9                  60 ± 10            54.6 ± 14.7        53.5 ± 15.4   59.5 ± 9.8                    (53.5--61.4)
  Mean paCO~2~(mmHg)           nr        nr       30 ± 5                  33 ± 5             41.7 ± 15          42.1 ± 16.5   32.9 ± 9.8                    (30--42.1)
  Mean \[D(A-a)O~2~\] (mmHg)   nr        46.6     nr                      nr                 45.3 ± 22.4        44.8 ± 21.6   nr                            (44.8--46.6)

**Abbreviations:** paO~2~, oxygen arterial partial pressure; paCO~2~, dioxide arterial partial pressure; D(A-a)O~2~, alveolar-arterial oxygen gradient; nr, not reported nr, not reported; RBBB, right bundle branch block.

Pre-test clinical probability and D-Dimer
-----------------------------------------

Two studies have analyzed the field of applicability of PTP combined with D-Dimer for ruling out PE in the elderly ([@b42]; [@b47]). These studies have reported that the percentage of high PTP increases in elderly compared to younger patients, whereas the percentage of low PTP decreases. One study suggested that Geneva score seemed to perform better in elderly patients compared to Wells score ([@b42]). One of these studies has demonstrated that the sensitivity and negative predictive value of a combination of low PTP and negative D-Dimer were high in elderly patients. Unfortunately the prevalence of elderly having the association non high PTP-negative D-Dimer is low (14% of age over than 75 years) (Sühne et al 2005). However a strategy combining PTP and D-Dimer is still cost-effectiveness at least until 80 years ([@b44]).

The specificity of D-Dimer in patients with suspected PE decreases steady with age. One study has demonstrated that the specificity of ELISA D-Dimer (VIDAS, Biomerieux, France) in suspected VTE reduces from 70.5% in patients under 40 years to 4.5% in patients over 80 years ([@b19]). Similar specificity (5%) was found in another study in patients over 80 years with nonhigh PTP by using the same ELISA D-Dimer method ([@b41]). The very low specificity of D-Dimer in the elderly has led to suggest an increased cut-off value of D-Dimer. Two series have concluded that an increased cut-off of D-Dimer reduced the false positives but increased the percentage of false negatives. Conversely, another study has demonstrated that increasing the cut-off from 500 microg/L to 750 microg/L and 1000 microg/L, led to a rise in D-Dimer specificity in patients over 80 years (from 4.5% to 13.1% and 27.3%, respectively) without loss of sensibility ([@b2]; [@b40]; [@b19]).

One study ([@b31]) has shown that 86% of patients with PE had D-Dimer \>500 μg/L measured with latex agglutination. In another study D-Dimer, measured by immunoturbidimetric method, was over the cut-off value in 98.5% of patients (Sühne et al 2005). Four studies demonstrated that all patients (100%) had D-Dimer values higher than cut-off ([@b55]; [@b3]; [@b31]; [@b9]).

Instrumental examinations for confirming PE
-------------------------------------------

Two studies have analyzed the effect of age on the diagnostic performance of helical angio-CT to diagnose PE. Either by single detector or multidetector helical pulmonary angio-CT, the sensitivity, specificity, positive, and negative predictive values are not influenced by age, making applicable and safe the diagnostic strategies based on these investigations ([@b42]; [@b48]).

In selected elderly patients without previous cardiopulmonary diseases ventilation/perfusion (V/Q) lung scan has similar applicability in the elderly compared with younger patients ([@b50]). In unselected patients, rate of non diagnostic lung scan is higher in elderly patients ([@b8]). The diagnostic yield of lung scan decreases from 68% in patients under 40 years to 42% in the patients aged 80 years and older ([@b41]).

Sensitivity of legs ultrasonography for detection of DVT increase with age, whereas specificity does not change with age, close to 100% ([@b41]).

Sensitivity and specificity of pulmonary angiography remain similar to young adults but this procedure could be limited by higher risk of acute renal failure due to iodinate contrast ([@b49]).

A recent meta-analysis on prognostic values of cardiac troponins has shown that elevated levels of troponins identify high risk patients for death and adverse outcomes, even though in the studies concerning patients with mean age ≥65 years. ([@b13]; [@b11]; [@b21]; [@b23]; [@b5]). One study has evaluated the prognostic role of BNP in the elderly, and concluded that this biomarker was not a solid indicator of complicated PE ([@b38]).

Discussion and implications for clinical practice
=================================================

The two crucial questions about PE in the elderly are: in which patients should PE be suspected and searched for, and which diagnostic procedures and algorithms could be safely performed.

PE represents one of the main causes of acute respiratory failure (ARF) in the elderly patients. In a recent observational study on 514 elderly patients with ARF, 18% of them had confirmed PE. An inappropriate initial treatment due to uncorrected diagnosis was associated to an increased mortality ([@b38]). PE was one of the main causes incorrectly diagnosed ([@b38]).

In elderly patients, making the difference between PE symptoms and other cardio-respiratory diseases such as congestive heart failure, pneumonia and/or COPD (chronic obstructive pulmonary disease) exacerbation could be very challenging because of the frequent similar clinical picture and coexistence of diseases ([@b38]). As shown in the present study, the most frequent symptoms and signs of confirmed PE in elderly patients are dyspnea, tachypnea, tachycardia, and chest pain. All these symptoms and signs are nonspecific and similar to that of PE in younger patients ([@b56]; [@b32]; [@b16]). Chest pain seem to be less frequent and tachycardia and syncope more frequent in the elderly compared with nonelderly patients ([@b7]; [@b49]; [@b14]; [@b25]; [@b35]). Bed rest is the most frequent risk factors for PE in the elderly, together with surgery and cancer. Evident implication is that primary prophylaxis using mechanical or pharmacological measures should be carefully evaluated in elderly bedridden patients. ([@b56]; [@b32]; [@b16]).

The specificity of instrumental and laboratory examinations is low both in elderly and nonelderly patients: 12-leads-ECG, chest X-ray, and ABG do not increase the suspicion of PE in the elderly.

ABG could reveal an hypoxemic respiratory failure associated to normal or mildly reduced PaCO~2~ and increased D(A-a)O~2~ similarly to congestive heart failure and pneumonia. It should be kept in mind that in two studies enrolling patients with previous cardio-pulmonary diseases, mean values of PaCO~2~ were in normal range. Only one third of patients had respiratory alkalosis ([@b31]; [@b9]), suggesting an impaired response to acute stress in elderly patients. Compared with younger patients, ABG in elderly patients seems to reveal lower hypoxemia and higher values of alveolar-arterial oxygen gradient ([@b56]).

The role of D-Dimer is well recognized to rule out PE when it is negative and associated to a non-high PTP. However, the specificity and the clinical usefulness of D-Dimer decrease with age because of high percentage of elderly patients with D-Dimer higher than cut-off. Unfortunately increasing cut-off of D-Dimer could lead to increase the percentage of patients wrongly considered negatives, and is therefore considered unsafe.

Recently, the first diagnostic algorithm, not validated, for suspected PE in the elderly has been reported ([@b43]). The most important findings of this diagnostic strategy are represented by the non invasivity of first-line investigation (PTP evaluation, and legs ultrasonography), and angio-CT as confirming examination. In this algorithm D-Dimer is not widely recommended; its assay should be reserved to selected conditions (limited availability of other diagnostic tests or presence of high risk of adverse reactions due to instrumental examinations with contrast). However, more recently the same Authors demonstrated that in elderly outpatients the strategies based on PTP evaluation, and D-Dimer assay are cost-effectiveness at least until 80 years and that strategies with legs ultrasonography are more expensive but not safer. Therefore, measuring D-dimer in outpatients more than 80 years may be differently appreciated. On one side, one could argue that the clinical usefulness is so limited that D-dimer measurement is not indicated. On the other side, D-dimer measurement does not increase the costs of diagnostic strategies. To avoid complicated recommendations or age-adapted diagnostic strategies (for example not dosing D-dimer in elderly patients), a systematic measurement may be proposed, at least in outpatients. Moreover, D-dimer might still be justified in patients above 80 years when the availability of other diagnostic tests is limited or when the risk of imaging using hCT is higher because of impaired renal function.

Helical pulmonary angio-CT should be encouraged in the elderly since it has been proved to be safe and accurate in the oldest and since lung scan has limited accuracy in this subset of patients. ([@b50]; [@b41], [@b42]; [@b8]; [@b48]).

[Figure 1](#fig1){ref-type="fig"} shows an algorithm for elderly patients with suspected PE derived from the most recent evidence of literature.

![Diagnostic algorithm for elderly patients with suspected PE derived from literature evidence.](vhrm0403-629-01){#fig1}

Limits of the study
-------------------

We are aware of some limitations of our review. First we pooled data from heterogeneous studies with different methodology. This review was not systematic and could be scientifically subjected to criticism. Studies about diagnostic strategy for diagnosing PE in the elderly are lacking, and our conclusions are based upon small series. [Table 3](#tbl3){ref-type="table"} summarizes the implications of this review in the clinical practice.

###### 

Implications for clinical geriatric practice

  -----------------------------------------------------------------------------------------------------------------------------------------------
  Incidence, prevalence, morbidity and mortality increase steadily with age
  PE is the acute cause of death in the elderly that is least suspected by physicians
  Comorbidity could influence symptoms and signs
  Spectrum of differential diagnosis of PE is wider in elderly patients due to high prevalence of cardio-respiratory diseases in these patients
  Higher percentage of elderly patients have high PTP compared with younger patients
  Low percentage of elderly patients with suspected PE have nonhigh PTP and negative D-dimer
  Specificity of D-Dimer reduces with age
  Increased cut-off of D-Dimer could reduce false positives but, unfortunately, could increase false negatives
  12-leads electrocardiogram, chest X-ray and echocardiogram could have a lower specificity with respect to younger patients
  Hypoxemia and increased alveolar-arterial oxygen gradient have a high sensitivity and low specificity
  Respiratory and metabolic acidosis could be more frequent compared with younger patients
  Lung scan could be less useful in the elderly for higher percentage of patients with pre-existing pulmonary diseases or abnormal chest X-ray
  Single detector and multidetector pulmonary angio-CT seem to be not influenced by age
  Pulmonary angiography could be limited in the elderly because of the higher risk of side effects compared with younger patients
  -----------------------------------------------------------------------------------------------------------------------------------------------

Conclusion
==========

PE is a potentially life-threatening condition, difficult to diagnose in elderly patients. Misdiagnosis is more frequent in the elderly patients Clinical signs of PE are neither sensitive nor specific enough to rule in or out the diagnosis. Our review suggests that PE should be suspected in any elderly patient at risk with unexplained dyspnea, tachypnea, or tachycardia. However these findings are highly nonspecific, which reduces the diagnostic value.
